.25mg semaglutide Medscape | The FDA has approved once-daily oral 25 mg (Wegovy Pill, Novo Nordisk) as the first GLP-1 agonist pill for weight management. Wegovy 0.25mg FlexTouch - 0.25mg
Description
GLP-1RAs contribute to improved glycemic control by lowering glycated hemoglobin (HbA1c) and promoting weight loss without causing hypoglycemia, a notable advantage over sulfonylureas and meglitinides
[1] [2] Whilst Rybelsus is effective for many patients, some individuals may notice a reduction in its efficacy over timea phenomenon that can occur with various diabetes medications
Your provider may order tests if your history or intake raises a concern (thyroid issues, high blood sugar, liver history)
(2021) 10:e016947
without it, oral semaglutide essentially doesn't work
